In the final clinical trials plenary session of the American Association for Cancer Research (AACR) Annual Meeting 2023, researchers highlighted promising study results that suggest new approaches for difficult-to-treat adult and pediatric cancers. The session, Novel Biomarker-Driven Molecularly Targeted Therapy Trials, was originally presented on Tuesday, April 18, and can be viewed on the virtual meeting platform by registered Annual Meeting participants through July 19, 2023. Below is a discussion of four trials reported in the session.
Login Or Register To Read Full Story